New Risk • 10h
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (34% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 72% per year for the foreseeable future. Market cap is less than US$10m (UK£3.95m market cap, or US$5.29m). Minor Risk Latest financial reports are more than 6 months old (reported September 2025 fiscal period end). New Risk • Apr 14
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 91% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 91% per year for the foreseeable future. Market cap is less than US$10m (UK£6.29m market cap, or US$8.52m). New Risk • Mar 23
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: UK£7.02m (US$9.43m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 95% per year for the foreseeable future. Market cap is less than US$10m (UK£7.02m market cap, or US$9.43m). New Risk • Mar 01
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 95% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£11.0m market cap, or US$14.8m). New Risk • Jan 14
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 85% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£11.3m market cap, or US$15.2m). Major Estimate Revision • Dec 30
Consensus revenue estimates decrease by 42% The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from UK£45.9m to UK£26.8m. EPS estimate unchanged from -UK£0.0025 per share at last update. Specialty Retail industry in the United Kingdom expected to see average net income growth of 37% next year. Consensus price target down from UK£0.098 to UK£0.072. Share price rose 15% to UK£0.025 over the past week. Reported Earnings • Dec 25
First half 2026 earnings released: UK£0.003 loss per share (vs UK£0.003 loss in 1H 2025) First half 2026 results: UK£0.003 loss per share (in line with 1H 2025). Revenue: UK£11.6m (down 45% from 1H 2025). Net loss: UK£1.70m (loss narrowed 5.6% from 1H 2025). Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings. Anuncio • Sep 26
Mothercare plc, Annual General Meeting, Nov 12, 2025 Mothercare plc, Annual General Meeting, Nov 12, 2025. Location: westside 1, london road, hp3 9td, hemel hempstead United Kingdom Reported Earnings • Sep 25
Full year 2025 earnings released: EPS: UK£0.011 (vs UK£0.006 in FY 2024) Full year 2025 results: EPS: UK£0.011 (up from UK£0.006 in FY 2024). Revenue: UK£38.9m (down 31% from FY 2024). Net income: UK£6.20m (up 88% from FY 2024). Profit margin: 16% (up from 5.9% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings. New Risk • Jun 25
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 16% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (UK£16.2m market cap, or US$22.0m). New Risk • Jun 20
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (UK£14.7m market cap, or US$19.8m). New Risk • May 12
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 16% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£12.6m market cap, or US$16.6m). Recent Insider Transactions • Dec 20
Non-Executive Chairman recently bought UK£100k worth of stock On the 18th of December, Clive Whiley bought around 4m shares on-market at roughly UK£0.025 per share. This transaction increased Clive's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Clive's only on-market trade for the last 12 months. Anuncio • Nov 22
Mothercare plc Announces Resignation of Mark Newton from the Board Mothercare plc announced upon Clive Whiley’s appointment as Chairman, Mark Newton Jones agreed to return to the board as a non-executive director to lend his support to the Transformation Plan and subsequently the actions necessary to combat the impact of the pandemic and the Ukraine conflict on the business. Accordingly, following creation of the new India joint venture and coterminous refinancing, Mark had indicated his intention to stand down from the board at its AGM and has now resigned as a director. Anuncio • Oct 22
Mothercare plc, Annual General Meeting, Nov 19, 2024 Mothercare plc, Annual General Meeting, Nov 19, 2024. Location: westside 1, london road, hp3 9td, hemel hempstead United Kingdom Reported Earnings • Oct 19
First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023) First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is expected to decline by 5.6% p.a. on average during the next 4 years, while revenues in the Specialty Retail industry in the United Kingdom are expected to grow by 5.4%. Price Target Changed • Oct 18
Price target decreased by 17% to UK£0.11 Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year. Price Target Changed • Oct 18
Price target decreased by 17% to UK£0.11 Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year. New Risk • Sep 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 9.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Share price has been highly volatile over the past 3 months (9.7% average weekly change). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£18.9m market cap, or US$25.2m). New Risk • Jun 11
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£26.2m market cap, or US$33.4m). Price Target Changed • Apr 19
Price target increased by 15% to UK£0.15 Up from UK£0.13, the current price target is provided by 1 analyst. New target price is 180% above last closing price of UK£0.053. Stock is down 39% over the past year. The company is forecast to post earnings per share of UK£0.005 next year compared to a net loss per share of UK£0.00018 last year. Reported Earnings • Nov 28
First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023) First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. New Risk • Nov 26
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.3x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (10.0% average weekly change). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£29.9m market cap, or US$37.7m). Anuncio • Sep 27
Mothercare plc, Annual General Meeting, Oct 23, 2023 Mothercare plc, Annual General Meeting, Oct 23, 2023, at 10:00 Coordinated Universal Time. Location: Westside 1, London Road Hemel Hemsptead United Kingdom Agenda: To receive the Company's annual accounts, together with the directors' report, the strategic report, the directors' remuneration report and the auditors' report for the 52 weeks ended 25 March 2023; to approve the directors' remuneration report for the 52 weeks ended 25 March 2023; to re-elect Clive Whiley as a director of the Company; to re-elect Andrew Cook as a director of the Company; to re-elect Gillian Kent as a director of the Company; to re-elect Mark Newton-Jones as a director of the Company; to re-elect Brian Small as a director of the Company and to consider other business matters. Reported Earnings • Sep 24
Full year 2023 earnings released: EPS: UK£0 (vs UK£0.021 in FY 2022) Full year 2023 results: EPS: UK£0 (down from UK£0.021 in FY 2022). Revenue: UK£73.1m (down 11% from FY 2022). Net loss: UK£100.0k (down 101% from profit in FY 2022). Revenue is forecast to stay flat during the next 3 years compared to a 5.9% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. New Risk • Jul 25
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings are forecast to decline by an average of 34% per year for the foreseeable future. Minor Risks High level of debt (883% net debt to equity). Market cap is less than US$100m (UK£34.2m market cap, or US$44.0m). Price Target Changed • Mar 12
Price target decreased by 15% to UK£0.14 Down from UK£0.17, the current price target is an average from 2 analysts. New target price is 63% above last closing price of UK£0.086. Stock is down 30% over the past year. The company is forecast to post earnings per share of UK£0.0015 for next year compared to UK£0.021 last year. Board Change • Mar 12
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non Executive Director Brian Small was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 30
First half 2021 earnings released: UK£0.038 loss per share The company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£44.4m (down 56% from 1H 2020). Net loss: UK£14.1m (down 352% from profit in 1H 2020). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings. Reported Earnings • Sep 28
Full year earnings released - UK£0.02 loss per share Over the last 12 months the company has reported total losses of UK£7.20m, with losses narrowing by 67% from the prior year. Total revenue was UK£164.7m over the last 12 months, down 18% from the prior year. 
